Clinical Trial Update: Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2, single-arm trial evaluating BSI-201 in BRCA-associated advanced epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• BSI-201 (iniparib)

Snippet

Sponsor: Sanofi | Conditions: Primary Peritoneal Cancer, Advanced Epithelial Ovarian Cancer | Phase 2 | Status: COMPLETED